NOTCH2 and neoplasm: MTS experiment showed the cell viability was reduced to 74 ± 5.9, 61 ± 5.3, and 46.4 ± 4.6% in GH3 cells, and 94.5 ± 8.2, 88 ± 8.1, and 76 ± 7.4% in primary tumor cells after 24, 48, and 72 h knockdown of Notch2.